You are here:
Drug research
#

Drug research

Get Alerts

Articles

View all

Drugs haul: Vijender not off hook yet, Arjun awardee wrestler kingpin?

Mar 09, 2013

Drugs haul: Vijender not off hook yet, Arjun awardee wrestler kingpin?

Police said teams have been sent to different locations to nab wrestler Jagdish Bhola, a former Punjab police cop, named by Kahlon as the kingpin of the gang. #NewsTracker #Drug research #Drugs #Vijender Kumar #Punjab Police

BLOG POSTS

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

May 09, 2011

Flop show? Indian pharma rolls back its drug discovery ambitions

Indian pharmaceutical companies have tried to speed up drug discoveries by hiving research off into separate companies. But as the Piramal decision shows, they are re-merging these companies. Has the strategy failed? #Piramal Healthcare #Dr Reddy's #Sun Pharma #Drug research #NCEs #CorporateStrategy

Wire

View all

Flop show? Indian pharma rolls back its drug discovery ambitions

Sep 22, 2014

Drug giant Merck to buy St. Louis-based Sigma-Aldrich

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment. Darmstadt-based Merck KGaA. said Monday it ... #Massachusetts #Merck KGaA #Merck & Company, Inc. #Sigma-Aldrich
Flop show? Indian pharma rolls back its drug discovery ambitions

Sep 22, 2014

'Nightmare' bug puts patients at risk, says Calgary disease expert

A recent study by microbiologist Johann Pitout and his team of researchers at Calgary Laboratory Services found a dozen cases at health care facilities in Alberta over the last three years where patients were infected with microbes that even antibiot... #Massachusetts #Merck KGaA #Merck & Company, Inc. #Sigma-Aldrich
Flop show? Indian pharma rolls back its drug discovery ambitions

Sep 22, 2014

‘Nightmare’ bug puts patients at risk, says Calgary disease expert

Canadian hospitals risk fatal outbreaks and rising costs from a “nightmare” bacteria unless they begin routine screening and precautionary isolation of high-risk patients, warns an international expert on drug-resistant bugs. A recent study by microb... #Massachusetts #Merck KGaA #Merck & Company, Inc. #Sigma-Aldrich